Itxarone Bilbao

Summary

Affiliation: Hospital Universitari Vall d'Hebron
Country: Spain

Publications

  1. ncbi request reprint Our experience in liver transplantation in patients over 65 yr of age
    Itxarone Bilbao
    Liver Transplant Unit, Department of Surgery, Hospital Vall d Hebron, Barcelona, Spain
    Clin Transplant 22:82-8. 2008
  2. doi request reprint Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity
    I Bilbao
    Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitari Vall d Hebron, Barcelona, Spain Electronic address
    Transplant Proc 46:3104-7. 2014
  3. pmc A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
  4. doi request reprint Indications and management of everolimus after liver transplantation
    I Bilbao
    HBP Surgery and Transplant Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Transplant Proc 41:2172-6. 2009
  5. ncbi request reprint Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients
    Itxarone Bilbao
    Liver Transplantation Unit of the Department of General Surgery, Hospital Vall Hebron, Universidad Autonoma Barcelona, Spain
    Int Immunopharmacol 6:1977-83. 2006
  6. ncbi request reprint [Hepatic angiomyolipoma in two patients infected with hepatitis C virus]
    Itxarone Bilbao
    Unidad de Cirugía Hepatobiliopancreática, Servicio de Cirugia General, Unidad de Cirugía Hepatobiliopancreática y Trasplante Hepático, Hospital Vall d Hebron, Barcelona, Espana
    Gastroenterol Hepatol 30:222-8. 2007
  7. ncbi request reprint [Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]
    Itxarone Bilbao
    Servicio de Cirugía Hepatolobiliopancreática y Trasplante Hepático, Hospital Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, Barcelona, Spain
    Gastroenterol Hepatol 31:341-6. 2008
  8. doi request reprint Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series
    Gonzalo Sapisochin
    HBP Surgery and Transplantation Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, 08035 Barcelona, Spain
    World J Surg 34:2146-54. 2010
  9. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
  10. ncbi request reprint A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C
    Carlos Margarit
    Liver Transplantation Unit, Department of General Surgery, Hospital Vall Hebron, Universidad Autonoma Barcelona, Barcelona, Spain
    Transpl Int 18:1336-45. 2005

Collaborators

Detail Information

Publications31

  1. ncbi request reprint Our experience in liver transplantation in patients over 65 yr of age
    Itxarone Bilbao
    Liver Transplant Unit, Department of Surgery, Hospital Vall d Hebron, Barcelona, Spain
    Clin Transplant 22:82-8. 2008
    ..The aim of this study was to analyze short- and long-term results of liver transplantation (LT) in patients over 65 yr...
  2. doi request reprint Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity
    I Bilbao
    Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitari Vall d Hebron, Barcelona, Spain Electronic address
    Transplant Proc 46:3104-7. 2014
    ..It allows neurologic function to be recovered while maintaining adequate liver function...
  3. pmc A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
    ..Therefore, we designed a prospective RCT to determine if the mTOR inhibitor sirolimus can improve hepatocellular carcinoma (HCC)-free patient survival in liver transplant (LT) recipients with a pre-transplant diagnosis of HCC...
  4. doi request reprint Indications and management of everolimus after liver transplantation
    I Bilbao
    HBP Surgery and Transplant Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Transplant Proc 41:2172-6. 2009
    ..Our aim was to assess our experience with the use and management of everolimus after orthotopic liver transplantation (OLT)...
  5. ncbi request reprint Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients
    Itxarone Bilbao
    Liver Transplantation Unit of the Department of General Surgery, Hospital Vall Hebron, Universidad Autonoma Barcelona, Spain
    Int Immunopharmacol 6:1977-83. 2006
    ..To analyze our results with mycophenolate mofetil (MMF) in stable liver transplantation (LT) patients presenting with adverse events (AE) related to prolonged use of calcineurin inhibitors (CNI)...
  6. ncbi request reprint [Hepatic angiomyolipoma in two patients infected with hepatitis C virus]
    Itxarone Bilbao
    Unidad de Cirugía Hepatobiliopancreática, Servicio de Cirugia General, Unidad de Cirugía Hepatobiliopancreática y Trasplante Hepático, Hospital Vall d Hebron, Barcelona, Espana
    Gastroenterol Hepatol 30:222-8. 2007
    ..The aim of this study is to present our experience with two cases of hepatic angiomyolioma in hepatitis C virus (HCV) positive patients, and to up-date the clinical manage, diagnostic and treatment of this entity...
  7. ncbi request reprint [Krukenberg's tumor as the first clinical manifestation of fibrolamellar hepatocarcinoma]
    Itxarone Bilbao
    Servicio de Cirugía Hepatolobiliopancreática y Trasplante Hepático, Hospital Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, Barcelona, Spain
    Gastroenterol Hepatol 31:341-6. 2008
    ..Although ovarian involvement in primary digestive tumors is possible, hepatic origin is rare...
  8. doi request reprint Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series
    Gonzalo Sapisochin
    HBP Surgery and Transplantation Department, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Passeig de la Vall d Hebron 119 129, 08035 Barcelona, Spain
    World J Surg 34:2146-54. 2010
    ..The aim of this study was to ascertain the outcome of liver transplantation (LT) due to hepatocellular carcinoma (HCC) in patients who had undergone previous liver resection (LR) for HCC...
  9. doi request reprint Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis
    Gonzalo Sapisochin
    Department of HBP Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Surg Oncol 20:1194-202. 2013
    ..We aimed to assess the long-term outcome of cirrhotic patients with single HCC ≤5 cm treated either with LR or LT on an intention-to-treat basis...
  10. ncbi request reprint A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C
    Carlos Margarit
    Liver Transplantation Unit, Department of General Surgery, Hospital Vall Hebron, Universidad Autonoma Barcelona, Barcelona, Spain
    Transpl Int 18:1336-45. 2005
    ..The main advantage of this regimen could be in HCV patients, as recurrence of hepatitis in the graft was less severe in the group of patients in whom steroids could be avoided completely...
  11. ncbi request reprint Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation
    Carlos Margarit
    Liver Transplantation Unit, Department of Surgery, Hospital Vall Hebron, Universidad Autonoma, Barcelona, Spain
    Liver Transpl 11:1242-51. 2005
    ..Salvage liver transplantation was performed in 16.2% of resected patients, with older age being the main contraindication. Outcome of salvage LT was similar to that of primary LT...
  12. ncbi request reprint Liver transplantation in HIV-HCV coinfected patients: a case-control study
    Lluis Castells
    Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Transplantation 83:354-8. 2007
    ..1%) of the control group and one patient (20%) of the HIV group presented a sustained virologic response (P=NS). Short- to midterm results of LT in HIV-HCV co-infected patients were excellent and similar to non-HIV patients...
  13. ncbi request reprint Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients
    Lluis Castells
    Liver Unit, Department of Medicine, Hospital Universitari Vail d Hebron, Barcelona, Spain
    Antivir Ther 11:1061-70. 2006
    ..To investigate the efficacy of early antiviral treatment for hepatitis C virus (HCV) recurrence in HIV/HCV-coinfected patients undergoing liver transplantation for end-stage liver disease...
  14. doi request reprint Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Passeig Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatobiliary Pancreat Sci 18:268-75. 2011
    ..The aim of this study was to analyze the outcome of patients undergoing hepatic resection for melanoma liver metastases...
  15. ncbi request reprint Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?
    Isabel Campos-Varela
    Liver Unit, Department of Internal Medicine, Hospital Universitario Vall d Hebron, Barcelona, Spain
    Ann Hepatol 10:180-7. 2011
    ..The risk of recurrent hepatitis B virus (HBV) infection and prognosis of liver transplantation in patients with HBV has dramatically changed with the use of prophylaxis including hepatitis B immune globulin (HBIg) and antiviral agents...
  16. doi request reprint Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer
    Mireia Caralt
    Department of Hepatobiliopancreatic Surgery and Transplants, Hospital Universitari Vall d Hebron, Paseo Vall d Hebron119 129, Barcelona, 08035, Spain
    Ann Surg Oncol 15:2804-10. 2008
    ..Metastatic breast cancer is considered an incurable disease despite new therapies. Recent studies suggest that liver resection associated with systemic treatment may improve patient survival...
  17. ncbi request reprint Predictive factors for early mortality following liver transplantation
    Itxarone Bilbao
    Liver Transplant Unit of the Department of Surgery, Hospital Vall d Hebron, Barcelona, Spain
    Clin Transplant 17:401-11. 2003
    ..To retrospectively review our liver transplant performance to identify factors that influenced early outcomes and to prospectively test their validity in predicting outcomes...
  18. pmc Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre
    Gonzalo Sapisochin
    Department of Hepatobiliopancreatic Surgery and Transplantation, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Hepatol Int 5:707-15. 2011
    ..The long-term outcome of patients developing de novo neoplasm (DN) at our centre was evaluated...
  19. doi request reprint Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study
    Cristina Pérez-Cameo
    Liver Unit, Department of Internal Medicine, Vall d Hebron Hospital, Barcelona, Spain
    Liver Transpl 20:856-63. 2014
    ..45). At 6 months, the risk factors for mortality were a MELD score > 18 (OR = 3.08), being an LT recipient (OR = 3.47), a known etiology (OR = 2.08), and the presence of hepatocellular carcinoma (OR = 3.73)...
  20. doi request reprint Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients
    Fernando Salvador
    Department of Infectious Diseases, Vall d Hebron University Hospital, Barcelona, Spain
    Liver Transpl 17:1304-8. 2011
    ..We also provide a review of the literature and emphasize donor screening and preventive measures...
  21. ncbi request reprint Liver transplantation for malignant diseases: selection and pattern of recurrence
    Carlos Margarit
    Liver Transplantation Unit, Department of Surgery, Hospital General Vall Hebron, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
    World J Surg 26:257-63. 2002
    ..Liver transplantation for other malignancies is admitted only in fibrolamellar hepatoma, hepatoblastoma, epithelioid hemangioendothelioma without extrahepatic disease, and in metastases from carcinoid tumors...
  22. ncbi request reprint Does Matching Donor-Recipient Age Affect Long-Term Survival in Liver Transplantation?
    Cristina Dopazo
    Department of HPB Surgery and Transplants, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Ann Transplant 21:708-716. 2016
    ..40, p 0.074) and <60 years (HR 1.47, p 0.070). CONCLUSIONS Older donor age did not negatively affect survival regardless of recipient age, and comparable outcomes were achieved without an increased rate of complications...
  23. doi request reprint Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study
    Jesús Quintero
    Pediatric Liver Transplant Unit, Hospital Universitario Vall d Hebron, Universidad Autonoma de Barcelona, Barcelona, Spain
    Pediatr Transplant 18:185-9. 2014
    ..These results may implicate low AT-III levels in the etiology of eHAT post-LT. However, this is a small single-center pilot study and further larger prospective trials are required to confirm these results...
  24. doi request reprint Liver biopsy-related infection in liver transplant recipients: A current matter of concern?
    Cristina López Sánchez
    Departments of Infectious Diseases, Autonomous University of Barcelona, Barcelona, Spain
    Liver Transpl 20:552-6. 2014
    ....
  25. ncbi request reprint Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation
    Victor Vargas
    Liver Transplant Unit, Hospital Vall d Hebron, Universidad Autonoma de Barcelona, Paseo Vall d Hebron 119, 08035, Barcelona, Spain
    Transpl Int 16:270-5. 2003
    ....
  26. pmc Isolated bilateral Tapia's syndrome after liver transplantation: A case report and review of the literature
    Itxarone Bilbao
    Itxarone Bilbao, Cristina Dopazo, Mireia Caralt, Lluis Castells, Elisabeth Pando, Amaia Gantxegi, Ramón Charco, Department of Digestive Surgery, Hepatobiliopancreatic Surgery and Liver Transplant Unit, Hospital Universitario Vall d Hebron, CIBERehd, Universidad Autonoma de Barcelona, 08035 Barcelona, Spain
    World J Hepatol 8:1637-1644. 2016
    ..To describe one case of bilateral Tapia's syndrome in a liver transplanted patient and to review the literature...
  27. doi request reprint [Early detection, prevention and management of renal failure in liver transplantation]
    Lluis Castells
    Servicio de Medicina Interna Hepatología, Hospital Vall d Hebron, Barcelona, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Barcelona, España Electronic address
    Gastroenterol Hepatol 37:480-91. 2014
    ..In addition, this document also provides an update of the various immunosuppressive regimens tested in this population for the prevention and control of post-transplantation deterioration of renal function. ..
  28. doi request reprint Indocyanine green plasma disappearance rate: a new tool for the classification of paediatric patients with acute liver failure
    Jesús Quintero
    Pediatric Liver Transplant Unit, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Catalunya, Spain
    Liver Int 34:689-94. 2014
    ..The present study assessed the use the of indocyanine green plasma disappearance rate as a tool to predict the evolution of pediatric patients with acute liver failure...
  29. ncbi request reprint Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
    Lluis Castells
    Liver Unit, Internal Medicine Department, Hospital General Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Ps Vall d Hebron 119 129, 08035 Barcelona, Spain
    J Hepatol 43:53-9. 2005
    ..The efficacy and safety of treatment with pegylated interferon alpha-2b (Peg-Intron, 1.5 microg/kg) and ribavirin (400-800 mg) in the acute phase of recurrent HCV after LT is presented...
  30. ncbi request reprint Xanthine oxidoreductase and preservation injury in human liver transplantation
    Ramon Marti
    Biochemistry Department, Hospital Universitari Vall d Hebron, Barcelona, Spain
    Transplantation 77:1239-45. 2004
    ..Oxidative damage is considered to be the first event leading to graft damage. Xanthine oxidoreductase (XOR) and neutrophil activation, two sources of reactive oxygen species, could play a role in the development of graft dysfunction...
  31. ncbi request reprint FK506 in the maturation of dendritic cells
    Joan Cos
    Centre de Transfusió i Banc de Teixits, Passeig Vall d Hebron 119 129, 08035 Barcelona, Spain
    Haematologica 87:679-87; discussion 687. 2002
    ..We investigated the effect of FK506 on DC differentiation from monocytes, and on the shift from immature to mature immunophenotypes...